V

Verve Therapeutics
D

VERV

7.28000
USD
-0.55
(-7.06%)
مغلق
حجم التداول
40,860
الربح لكل سهم
-3
العائد الربحي
-
P/E
-3
حجم السوق
616,352,755
نظرة عامةالتوصياتالأفكار والتحليلاتالأخبار
الأخبار
المقالات

العنوان: Verve Therapeutics

القطاع: Healthcare
الصناعة: Biotechnology
Verve Therapeutics Inc is a genetic medicines company pioneering a new approach to the care of cardiovascular disease, transforming treatment from chronic management to single-course gene editing medicines. The company's initial two programs target PCSK9 and ANGPTL3, genes that have been extensively validated as targets for lowering blood lipids such as low-density lipoprotein cholesterol, a root cause of cardiovascular disease. The company views its operations as and manages its business in one operating segment operating exclusively in the United States.